Sei Investments CO Xenon Pharmaceuticals Inc. Transaction History

Sei Investments CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$36.25 - $43.75 $1,522 - $1,837	-42 Reduced 0.53%	7,909 $308,000
Q1 2024 May 07, 2024	SELL	$42.66 - $50.04 $9,726 - $11,409	-228 Reduced 2.79%	7,951 $342,000
Q4 2023 Feb 14, 2024	SELL	$28.7 - $46.46 $4,534 - $7,340	-158 Reduced 1.9%	8,179 $376,000
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $208,034 - $241,955	-6,090 Reduced 42.21%	8,337 $284,000
Q2 2023 Aug 11, 2023	BUY	$34.84 - $43.54 $502,636 - $628,151	14,427 New	14,427 $555,000

212

70.2M

88.3K

28.8K

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.42B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.